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Editorial Comment
Which oracle to use for tracking a desynchronized heart? 
A matter of predictability in contemporary medicine
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“One theory is scientific to the extent that can be disproved.” 
Karl Popper
In diseased hearts, an electrical dyssynchrony caused by an 
altered velocity and uniformity of electrical propagation may 
result in areas of activation delay (1); when the delay has a cer-
tain pattern, it is also observed on the surface 12-lead ECG as a 
lengthening of the QRS complex. The functional consequence of 
this delay may be a mechanical dyssynchrony. As indicated by 
Kass (2), cardiac dyssynchrony should be distinguished from 
dyssynergy, which refers to a difference in function and not tim-
ing. We can distinguish at least three types of mechanical dys-
synchrony: atrio-ventricular, inter-ventricular, and intra-ventric-
ular. Because mechanical dyssynchrony can manifest without 
QRS elongation (3), particularly in an infarcted myocardium, all 
these types of mechanical dyssynchrony can be accurately 
identified using a combination of echocardiographic techniques 
including simple M-mode pulsed/continuous Doppler, pulsed tis-
sue Doppler (up to specific applications and usually offline), 
color tissue velocity imaging, strain rate imaging, real-time 
three-dimensional reconstruction (4), and speckle-tracking 
echocardiography (STE) (5), even if the agreement between 
these approaches is variable (6).
It is well established that a defective electromechanical 
coupling may depress the ejection fraction of the left ventricle 
(7) and cause cardiac pathological remodeling that occurs with 
dilation of the left ventricle and further deterioration of the ven-
tricular function over time, according to a known vicious circle, 
which also depends on the factor that caused heart failure (HF). 
The solution to the problem consists in starting a process of 
reverse remodeling by optimizing medical therapy with drugs of 
proven efficacy such as angiotensin-converting enzyme inhibi-
tors (ACEi) and beta-blockers. In this context the process of 
fibrosis in atria (8) and in ventricles is both pathological marker 
and therapeutic target because it has been demonstrated in 
arterial hypertension with some classes of drugs acting on the 
renin–angiotensin-aldosterone system (9). More recently, a new 
therapeutic option in HF has gained ground with the introduction 
of cardiac resynchronization therapy or CRT. This approach was 
previously tested in the atrioventricular dyssynchrony in 1990 
(10) using bicameral pacemakers and subsequently extended to 
ventricular dyssynchrony by adding a pacing lead in the left 
ventricle to the existing standard pacemakers or defibrillators 
with usually only a right ventricular lead (11). Thus far, CRT is 
tailored for patients with QRS>120 ms and LVEF≤35%, and at 
least, moderate symptoms of chronic HF. One of the main prob-
lems is that at least 30%-50% of patients undergoing CRT fail to 
respond adequately, or in some cases, HF worsens (12), and 
QRS duration does not accurately distinguish responders to CRT 
(13); furthermore, the LVEF 35% criterion, as suggested by a 
post-hoc analysis of the PROSPECT study (14), has proved to be 
not always appropriate. In the complex interplay between diag-
nostic and therapeutic tools, the situation appears to be confus-
ing (6, 15) and this problem is part of a more recent question that 
results from the application of probabilistic data to medical 
choices: can the mathematical-statistical models support clini-
cal decision making? These models, indeed, are imperfect rep-
resentations of the reality because they are built on relatively 
limited groups of studied subjects, and therefore, their predict-
ability is limited. In recent years when clinical decisions are 
forced by the practical guidelines, which are the operational 
consequence of this probabilistic approach, recover of only an 
individual patient appears impossible. For all those of us who 
believe in a medicine tailored to each patient, the question on 
which oracle you must consult to track a desynchronized heart 
remains unavoidable.
In the current issue of Anatol J Cardiol published “Apical 
transverse motion is associated with speckle-tracking radial 
dyssynchrony in patients with non-ischemic dilated cardiomy-
opathy.” entitled by Gürel et al. (16), a preliminary experience of 
assessing apical transverse motion (ATM) as a surrogate 
parameter to assess regional temporal and functional left ven-
tricular inhomogeneities has been reported and compared with 
STE (17), a parameter that was tested in the Speckle-Tracking 
and Resynchronization trial (5). Even with some limitations, 
including the number of studied subjects and lack of a follow-up 
on the few CRT patients, the study confirm that ATM is associ-
ated with radial dyssynchrony assessed by STE supporting the 
concept of a certain overlap between the techniques to assess 
mechanical dyssynchrony, with peculiar pros and cons of each 
of the aforementioned approaches.
In search of more reliable criteria to overcome the puzzle of 
how to define and track a desynchronized heart (6), STE requires 
high quality images, including a high frame rate and second 
harmonic tool; defining the ROI, as in any other echocardio-
graphic gray scale analysis (18), is almost user dependent and 
the endocardial-epicardial borders are manually traced. 
Nevertheless, STE has been validated by accurate sonomicrom-
etry and tagged MRI and demonstrated to overcome one of the 
main limitations of tissue Doppler technology that requires the 
parallel orientation between the ultrasonic beam and wall 
motion direction (19). In this context, because a golden standard 
is not yet available, we must rely on multiparametric echocardio-
graphic score.
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